Eton Pharmaceuticals, Inc. (ETON) › Operating Cash FlowEton Pharmaceuticals, Inc. (ETON) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2018: -$8.14M2019: -$18.03M2020: -$22.35M2021: -$4.72M2022: $4.82M2023: $6.82M2024: $969.0K2025: $10.52M$10.52M2018Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$10.52M+986.1%2024$969.0K-85.8%2023$6.82M+41.4%2022$4.82M+202.1%2021-$4.72M+78.9%2020-$22.35M-24.0%2019-$18.03M-121.3%2018-$8.14M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share